CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 37 enrolled
Drug / intervention
varenicline +1 moredrug
Likely dose
varenicline 1.0 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00567008
NCT00567008Phase 2Completed
CompareCT.gov

A Double-Blind Placebo-Controlled Pilot Trial of Varenicline (Chantix) for the Treatment of Cocaine Dependence

University of Pennsylvania·interventional·Posted Dec 4, 2007·Updated Nov 7, 2013

In Brief

A Phase 2 clinical trial evaluating varenicline and placebo for Cocaine Dependence. Completed, enrolled 37 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether varenicline (Chantix), is effective for the treatment of cocaine dependence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 4, 2007
Enrollment StartDec 1, 2007
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 18.6 years ago

Interventions

vareniclinedrug

1.0 mg BID for 8 weeks

placebodrug

placebo BID for 8 weeks